Avoro Capital Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,199,342
| Closed | -$102M | – | 49 |
|
|
2023
Q2 | $102M | Sell |
2,199,342
-1,750,658
| -44% | -$81.3M | 1.39% | 17 |
|
|
2023
Q1 | $113M | Buy |
3,950,000
+1,424,445
| +56% | +$40.8M | 1.68% | 17 |
|
|
2022
Q4 | $78.8M | Buy |
2,525,555
+1,450,555
| +135% | +$45.3M | 1.18% | 18 |
|
|
2022
Q3 | $21.8M | Hold |
1,075,000
| – | – | 0.4% | 30 |
|
|
2022
Q2 | $16.7M | Hold |
1,075,000
| – | – | 0.33% | 31 |
|
|
2022
Q1 | $20.6M | Buy |
1,075,000
+512,500
| +91% | +$9.8M | 0.38% | 33 |
|
|
2021
Q4 | $14.2M | Sell |
562,500
-237,500
| -30% | -$6.01M | 0.24% | 35 |
|
|
2021
Q3 | $26.2M | Buy |
+800,000
| New | +$26.2M | 0.41% | 34 |
|